Stockscreener 앱 받기
14.68
2.43%
0.28
전일 마감가:
$14.40
열려 있는:
$14.47
하루 거래량:
3,289
Relative Volume:
0.01
시가총액:
$271.86M
수익:
$1.93M
순이익/손실:
$-7.96M
주가수익비율:
-0.00416
EPS:
-3530.8178
순현금흐름:
$-36.78M
1주 성능:
+3.95%
1개월 성능:
-14.24%
6개월 성능:
+62.53%
1년 성능:
+90.82%
1일 변동 폭
$14.47
$14.70
1주일 범위
$13.50
$14.81
52주 변동 폭
$3.39
$20.72
아발로 테라퓨틱스 Stock (AVTX) Company Profile
명칭
Avalo Therapeutics Inc
전화
410-522-8707
주소
1500 LIBERTY RIDGE DRIVE, WAYNE
Compare AVTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
14.69 | 265.66M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.70 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.52 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
837.58 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
305.03 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
347.27 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
아발로 테라퓨틱스 Stock (AVTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-02 | 개시 | Guggenheim | Buy |
| 2025-12-18 | 개시 | Mizuho | Outperform |
| 2025-09-17 | 재확인 | H.C. Wainwright | Buy |
| 2025-09-05 | 개시 | TD Cowen | Buy |
| 2025-08-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-02 | 재개 | H.C. Wainwright | Buy |
| 2025-03-25 | 개시 | Jefferies | Buy |
| 2025-03-25 | 개시 | Stifel | Buy |
| 2025-02-28 | 개시 | Piper Sandler | Overweight |
| 2025-02-21 | 개시 | Wedbush | Outperform |
| 2024-12-19 | 개시 | BTIG Research | Buy |
| 2024-10-24 | 개시 | H.C. Wainwright | Neutral |
| 2024-04-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-09-24 | 개시 | RBC Capital Mkts | Outperform |
모두보기
아발로 테라퓨틱스 주식(AVTX)의 최신 뉴스
Avalo Therapeutics Eyes Q2 2026 Phase IIb LOTUS Readout for AVTX-009 in Hidradenitis Suppurativa - Yahoo Finance
AVTX: Phase 2b LOTUS trial for AVTX-009 in HS nears Q2 data, targeting rapid phase 3 and new indications - TradingView
Dow Update: Will Avalo Therapeutics Inc outperform the market in YEARRate Hike & Long-Term Capital Growth Ideas - baoquankhu1.vn
Avalo Therapeutics shares jump as Guggenheim starts coverage with buy - MSN
Avalo Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Biotech firm Avalo will stream two investor talks in February - Stock Titan
Avalo Therapeutics Stock Has More Than 200% Upside? Analyst Breaks Down Bull And Bear Case - Benzinga
Guggenheim Initiates Coverage of Avalo Therapeutics (AVTX) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage on Avalo Therapeutics (AVTX) with - GuruFocus
Avalo Therapeutics stock rises after Guggenheim initiates with Buy rating By Investing.com - Investing.com Australia
Avalo Therapeutics stock rises after Guggenheim initiates with Buy rating - Investing.com
Guggenheim Begins Coverage on Avalo Therapeutics (NASDAQ:AVTX) - MarketBeat
Guggenheim initiates Avalo Therapeutics stock with Buy rating on IL-1β therapy - Investing.com UK
Guggenheim initiates Avalo Therapeutics stock with Buy rating on IL-1β therapy By Investing.com - Investing.com India
Avalo Therapeutics Completes Enrollment for AVTX-009 Trial - Intellectia AI
Avalo Therapeutics Highlights AVTX-009 Progress in HS - TipRanks
Aug Update: Is Avalo Therapeutics Inc in a bullish channelJuly 2025 Short Interest & Expert Curated Trade Setups - baoquankhu1.vn
Avalo Therapeutics Advances in Hidradenitis Suppurativa Treatment with AVTX-009 Study - MSN
Patterns Watch: Is Avalo Therapeutics Inc a potential multi bagger2025 Top Gainers & Safe Entry Zone Tips - baoquankhu1.vn
Market Pulse: What is the long term forecast for Renovaro Inc stock2025 Geopolitical Influence & Comprehensive Market Scan Reports - baoquankhu1.vn
Gainers Report: Can Avalo Therapeutics Inc outperform under higher oil pricesJuly 2025 Price Swings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $32.71 Consensus Price Target from Analysts - Defense World
Market Wrap: What is the target price for DXLG stock2025 Retail Activity & AI Based Trade Execution Alerts - baoquankhu1.vn
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Up 38.2% in December - MarketBeat
Avalo Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of trial data By Investing.com - Investing.com South Africa
Avalo Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of trial data - Investing.com Nigeria
Avalo Therapeutics' (AVTX) Buy Rating Reiterated at HC Wainwright - MarketBeat
Aug Summary: What analysts say about Avalo Therapeutics Inc stockTreasury Yields & Detailed Earnings Play Alerts - baoquankhu1.vn
Avalo Therapeutics (AVTX) Gets 'Buy' Rating Reiteration from HC Wainwright | AVTX Stock News - GuruFocus
Retail Trends: Is Avalo Therapeutics Inc stock a safe investment in uncertain markets2025 Winners & Losers & Reliable Momentum Entry Alerts - Bộ Nội Vụ
Insider Sell: Is Avalo Therapeutics Inc stock positioned for digital transformationJuly 2025 Technicals & AI Optimized Trading Strategy Guides - Bộ Nội Vụ
Will Avalo Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Retail & Step-by-Step Trade Execution Guides - Улправда
Will Avalo Therapeutics Inc. stock split attract more investorsEarnings Overview Summary & Risk Controlled Swing Alerts - Улправда
Moving Averages: Will Avalo Therapeutics Inc. stock split attract more investorsWall Street Watch & Safe Entry Trade Signal Reports - Улправда
Is Avalo Therapeutics Inc. stock positioned well for digital economy2025 Risk Factors & High Accuracy Swing Trade Signals - Улправда
Avalo Therapeutics Reports Q3 2025 Financial Results - MSN
Avalo Therapeutics Files $750 Million Mixed Shelf - marketscreener.com
Avalo Therapeutics files for mixed shelf of up to $750 millionSEC filing - marketscreener.com
What margin trends mean for Avalo Therapeutics Inc. stockSwing Trade & Technical Pattern Based Signals - Улправда
Aug Momentum: Will Avalo Therapeutics Inc. stock benefit from AI adoptionAnalyst Downgrade & Accurate Intraday Trading Signals - ulpravda.ru
Is Avalo Therapeutics Inc. stock attractive after correctionPortfolio Risk Summary & Stepwise Entry and Exit Trade Signals - Улправда
Why analysts remain bullish on Avalo Therapeutics Inc. stockSwing Trade & Fast Gaining Stock Strategy Reports - ulpravda.ru
Options Flow: What margin trends mean for Avalo Therapeutics Inc stockGap Down & Weekly Sector Rotation Insights - Bộ Nội Vụ
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Avalo Therapeutics (AVTX) and Lifestance Health Group (LFST) - The Globe and Mail
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Would You Still Hold Avalo Therapeutics Stock If It Fell 30%? - Trefis
How rising interest rates impact Avalo Therapeutics Inc. stock2025 Trading Recap & Capital Protection Trade Alerts - DonanımHaber
Avalo Therapeutics (NASDAQ:AVTX) Upgraded by Mizuho to "Strong-Buy" Rating - MarketBeat
Will Avalo Therapeutics Inc. (C6K0) stock announce special dividend2025 Market Outlook & Fast Moving Stock Trade Plans - DonanımHaber
Can Avalo Therapeutics Inc. (C6K0) stock survive global slowdownWeekly Stock Summary & Fast Entry Momentum Alerts - DonanımHaber
아발로 테라퓨틱스 (AVTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.22%
자본화:
|
볼륨(24시간):